Mechanistic Pathways · 10 min read · 2027-11-04
Spirulina and ACC-Malonyl-CoA
A single metabolite — malonyl-CoA — decides whether cells build fat or burn it. One enzyme controls the switch.
ACC and Malonyl-CoA
Acetyl-CoA carboxylase (ACC1 cytosolic, ACC2 mitochondrial outer membrane) converts acetyl-CoA to malonyl-CoA. ACC1-derived malonyl-CoA is the lipogenesis substrate. ACC2-derived malonyl-CoA allosterically inhibits CPT1, blocking mitochondrial fatty acid import for β-oxidation. Both effects favor energy storage over expenditure.
AMPK Phosphorylates and Inactivates ACC
AMPK phosphorylates ACC1 at Ser79 and ACC2 at Ser221, inactivating both. The result: reduced lipogenesis (cytosolic) AND increased fatty acid oxidation (mitochondrial) simultaneously. This dual switch underlies the metabolic effects of caloric restriction, exercise, metformin, and spirulina. Bempedoic acid pharmacologically inhibits ACC clinically.
Conclusion
Spirulina's AMPK activation drives the ACC-malonyl-CoA metabolic switch toward fat burning. This is one of the most mechanistically validated and downstream- consequential effects of spirulina — explaining its NAFLD improvement, weight loss support, and metabolic flexibility benefits in clinical trials. The ACC/malonyl-CoA node is the central nexus where energy sensing meets metabolic flux.